Format
Sort by

Send to

Choose Destination

Search results

Items: 15

1.

Reply.

Binder PS, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK, Peipert JF, Kallogjeri D, Brooks RA.

Am J Obstet Gynecol. 2017 Feb;216(2):192-193. doi: 10.1016/j.ajog.2016.09.084. No abstract available.

PMID:
27640937
2.

Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.

Binder PS, Peipert JF, Kallogjeri D, Brooks RA, Massad LS, Mutch DG, Powell MA, Thaker PH, McCourt CK.

Am J Obstet Gynecol. 2016 Dec;215(6):766.e1-766.e9. doi: 10.1016/j.ajog.2016.07.035.

PMID:
27457116
3.

Transvaginal Ultrasound-Guided Biopsy of Deep Pelvic Masses: How We Do It.

Plett SK, Poder L, Brooks RA, Morgan TA.

J Ultrasound Med. 2016 Jun;35(6):1113-22. doi: 10.7863/ultra.15.08002. Review.

PMID:
27091918
4.

The economic impact of surgical care for morbidly obese endometrial cancer patients: a nationwide study.

Brooks RA, Blansit K, Young-Lin N, Usach I, Chen LM, Yu X, Kapp DS, Chan JK.

Am J Obstet Gynecol. 2016 Apr;214(4):498.e1-6. doi: 10.1016/j.ajog.2015.10.015.

PMID:
26478102
5.

Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States.

Fuh KC, Shin JY, Kapp DS, Brooks RA, Ueda S, Urban RR, Chen LM, Chan JK.

Gynecol Oncol. 2015 Mar;136(3):491-7. doi: 10.1016/j.ygyno.2014.10.009.

PMID:
25455734
6.

Factors associated with publication of plenary presentations at the Society of Gynecologic Oncologists annual meeting.

Cohen JG, Kiet T, Shin JY, Sherman AE, Hamilton CA, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK.

Gynecol Oncol. 2013 Jan;128(1):128-31. doi: 10.1016/j.ygyno.2012.08.003.

PMID:
22892364
7.

Pelvic exenteration in gynecologic oncology: a single institution study over 20 years.

Benn T, Brooks RA, Zhang Q, Powell MA, Thaker PH, Mutch DG, Zighelboim I.

Gynecol Oncol. 2011 Jul;122(1):14-8. doi: 10.1016/j.ygyno.2011.03.003.

8.

Clinical and pathologic features of vulvar intraepithelial neoplasia in premenopausal and postmenopausal women.

Nugent EK, Brooks RA, Barr CD, Case AS, Mutch DG, Massad LS.

J Low Genit Tract Dis. 2011 Jan;15(1):15-9. doi: 10.1097/LGT.0b013e3181ee2598.

PMID:
21192171
9.

The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: survey results from members of the Society of Gynecologic Oncologists.

Dewdney SB, Rimel BJ, Reinhart AJ, Kizer NT, Brooks RA, Massad LS, Zighelboim I.

Gynecol Oncol. 2010 Oct;119(1):18-21. doi: 10.1016/j.ygyno.2010.06.021.

PMID:
20673970
10.

Novel imaging modalities in gynecologic cancer.

Brooks RA, Powell MA.

Curr Oncol Rep. 2009 Nov;11(6):466-72. Review.

PMID:
19840524
11.

Long-term assessment of bladder and bowel dysfunction after radical hysterectomy.

Brooks RA, Wright JD, Powell MA, Rader JS, Gao F, Mutch DG, Wall LL.

Gynecol Oncol. 2009 Jul;114(1):75-9. doi: 10.1016/j.ygyno.2009.03.036.

PMID:
19410279
12.

A unified sample preparation protocol for proteomic and genomic profiling of cervical swabs to identify biomarkers for cervical cancer screening.

Rader JS, Malone JP, Gross J, Gilmore P, Brooks RA, Nguyen L, Crimmins DL, Feng S, Wright JD, Taylor N, Zighelboim I, Funk MC, Huettner PC, Ladenson JH, Gius D, Townsend RR.

Proteomics Clin Appl. 2008 Dec;2(12):1658-69. doi: 10.1002/prca.200780146.

13.

Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancer.

Brooks RA, Rader JS, Dehdashti F, Mutch DG, Powell MA, Thaker PH, Siegel BA, Grigsby PW.

Gynecol Oncol. 2009 Jan;112(1):104-9. doi: 10.1016/j.ygyno.2008.08.028.

14.

Gene therapy in gynecological cancer.

Brooks RA, Mutch DG.

Expert Rev Anticancer Ther. 2006 Jul;6(7):1013-32. Review.

PMID:
16831074
15.

Long-term semi-permanent catheter use for the palliation of malignant ascites.

Brooks RA, Herzog TJ.

Gynecol Oncol. 2006 May;101(2):360-2.

PMID:
16499957
Items per page

Supplemental Content

Loading ...
Support Center